Cargando…

Lipopolysaccharide-Induced Cellular Activation May Participate in the Immunopathogenesis of Visceral Leishmaniasis Alone or in HIV Coinfection

Visceral Leishmaniasis (VL) is an infectious disease which constitutes a serious public health problem, integrating the list of neglected tropical diseases. The disease is characterized by a Leishmania-specific immune suppression T-cell depletion and a decrease of other hematopoietic cells. In paral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos-Oliveira, Joanna Reis, Da-Cruz, Alda Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432364/ https://www.ncbi.nlm.nih.gov/pubmed/22956960 http://dx.doi.org/10.1155/2012/364534

Ejemplares similares

Visceral Leishmaniasis and HIV Coinfection in Latin America
por: Lindoso, José Angelo, et al.
Publicado: (2014)

Evidence That Lipopolisaccharide May Contribute to the Cytokine Storm and Cellular Activation in Patients with Visceral Leishmaniasis
por: Santos-Oliveira, Joanna R., et al.
Publicado: (2011)

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
por: Monge-Maillo, Begoña, et al.
Publicado: (2014)

TREM-1 Expression on the Surface of Neutrophils in Patients With Visceral Leishmaniasis Is Associated With Immunopathogenesis
por: Bomfim, Lays Gisele Santos, et al.
Publicado: (2022)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Visceral leishmaniasis and HIV coinfection: current perspectives
por: Lindoso, José Angelo Lauletta, et al.
Publicado: (2018)

Is Visceral Leishmaniasis the same in HIV-coinfected adults?
por: Henn, Guilherme Alves de Lima, et al.
Publicado: (2018)

Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
por: van Griensven, Johan, et al.
Publicado: (2014)

Visceral Leishmaniasis Associated with HIV Coinfection in Pará, Brazil
por: Camargo Júnior, Raimundo Nonato Colares, et al.
Publicado: (2023)

Visceral leishmaniasis and COVID-19 coinfection – A case report
por: Pikoulas, Antonis, et al.
Publicado: (2021)

Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient
por: Martins, Luciamáre Perinetti Alves, et al.
Publicado: (2022)

Editorial: Immunology and immunopathogenesis of human leishmaniasis
por: de Menezes, Juliana P. B., et al.
Publicado: (2022)

Lower levels of leptin are associated with severity parameters in visceral leishmaniasis patients
por: Fievez, Aline Mireille da Cunha, et al.
Publicado: (2019)

Visceral leishmaniasis in a Brazilian endemic area: an overview of occurrence, HIV coinfection and lethality
por: Luz, João Gabriel Guimarães, et al.
Publicado: (2018)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Leishmaniasis and AIDS coinfection
por: Hozannah, Adriana, et al.
Publicado: (2013)

Evaluation of Cellular Phenotypes Implicated in Immunopathogenesis and Monitoring Immune Reconstitution Inflammatory Syndrome in HIV/Leprosy Cases
por: Giacoia-Gripp, Carmem Beatriz Wagner, et al.
Publicado: (2011)

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India
por: Mahajan, Raman, et al.
Publicado: (2015)

The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis
por: Gonçalves-de-Albuquerque, Suênia da C., et al.
Publicado: (2017)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Leishmania Transmission at the Village Level in Bihar, India
por: Cloots, Kristien, et al.
Publicado: (2021)

Factors associated with relapse and hospital death in patients coinfected with visceral leishmaniasis and HIV: a longitudinal study
por: Costa, Larissa D. L. N., et al.
Publicado: (2023)

Leishmaniasis–HIV coinfection: current challenges
por: Lindoso, José Angelo Lauletta, et al.
Publicado: (2016)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients
por: Silva-Freitas, Maria Luciana, et al.
Publicado: (2016)

Impaired Thymic Output Can Be Related to the Low Immune Reconstitution and T Cell Repertoire Disturbances in Relapsing Visceral Leishmaniasis Associated HIV/AIDS Patients
por: Silva-Freitas, Maria Luciana, et al.
Publicado: (2020)

Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment
por: Adam, Abubakr O. A., et al.
Publicado: (2014)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Leprosy and American cutaneous leishmaniasis coinfection
por: Mercadante, Larissa Mondadori, et al.
Publicado: (2018)

Tegumentary leishmaniasis and coinfections other than HIV
por: Martínez, Dalila Y., et al.
Publicado: (2018)

Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia
por: Franssen, Susanne U., et al.
Publicado: (2021)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

High levels of anti-Leishmania IgG3 and low CD4(+) T cells count were associated with relapses in visceral leishmaniasis
por: Kuschnir, Renata Caetano, et al.
Publicado: (2021)

Perceived quality of life among Visceral Leishmaniasis and HIV coinfected migrant male-workers in Northwest Ethiopia: a qualitative study
por: Alemayehu, Mekuriaw, et al.
Publicado: (2017)

First case of pulmonary tuberculosis and visceral leishmaniasis coinfection successfully treated with antituberculosis drug and liposomal amphotericin B
por: Hasnain, Md Golam, et al.
Publicado: (2014)

Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis
por: Costa, Sidnei Ferro, et al.
Publicado: (2020)

ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection
por: Galvani, Nathalia C., et al.
Publicado: (2021)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4mmgdhd85ab89d81s5qe9sk144